Clinical trial
Safety and Efficacy of Remimazolam Compared With Midazolam During Bronchoscopy: A Single Center, Randomized Controlled Study
NCT05994547 is registered in ClinicalTrials.gov with Chungbuk National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Remimazolam Compared With Midazolam During Bronchoscopy: A Single Center, Randomized Controlled Study
- Lead sponsor
- Chungbuk National University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 14, 2022
- Completion date
- June 15, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchoscopy, remimazolam